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Abstract 
A variety of piano-stool complexes of cyclopentadienyl ruthenium(II) with imidazole-based PN ligands 
have been synthesized starting from the precursor complexes [CpRu(C10H8)]PF6, [CpRu(NCMe)3]PF6 
and [CpRu(PPh3)2Cl]. PN ligands used are imidazol-2-yl, -4-yl and -5-yl phosphines.  
Depending on the ligand and precursor different types of coordination modes were observed; in the case 
of polyimidazolyl PN ligands these were κ1P-monodentate, κ2P,N-, κ2N,N- and κ3N,N,N- chelating and 
μ-κP:κ2N,N-brigding. The solid-state structures of[CpRu(1a)2Cl].H2O (5.H2O) and  [{CpRu(μ-κ2-N,N-
κ’1-P-2b)}2](C6H5PO3H)2(C6H5PO3H2)2, a hydrolysis product of the as well determined 
[{CpRu(2b)}2](PF6)2.2CH3CN (7b.2CH3CN) were determined (1a = imidazol-2-yldiphenyl phosphine, 
2b = bis(1-methylimidazol-2-yl)phenyl phosphine, 3a = tris(imidazol-2-yl)phosphine). Furthermore, the 
complexes [CpRu(L)2]PF6 (L = imidazol-2-yl or imidazol-4-yl phosphine) have been screened for their 
catalytic activity in the hydration of 1-octyne. 
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1. Introduction 
The addition of water to alkynes is an important step in the synthesis of carbonyl compounds and has a 
long history going back as far as 1860, when Berthelot discovered the hydration of acetylene in sulfuric 
acid.1 One of the longest known reactions to catalyze the hydration of alkynes is the reaction with 
mercury(II) salts.2,3,4 Even though mercury is extremely hazardous, this reaction is still the favoured 
process for industrial application because it is reliable and produces good yields.5 Other metal-based 
catalysts which catalyze the Markovnikov as well as anti-Markovnikov hydration include NaAuCl4, 
RuCl3 and [Ru(III)(EDTA-H)Cl], RhCl3, PtCl4 and the Zeise dimer [{PtCl3(CH2=CH2)}2], just to name 
a few.6,7,8,9,10,11,12,13 Besides these homogenous catalysts also heterogenous catalyst systems are 
used.14,15,16 
The first ruthenium(II) complex to be known to catalyze the anti-Markovnikov hydration was a 
phosphine complex described by Tokunaga and Wakatsuki.17,18 The catalytic activity as well as the 
selectivity of ruthenium(II) depends on the nature of the phosphine ligands.19 Using PPh2(C6F5) and 
P(3-C6H4SO3Na)3 as ligands leads to selective anti-Markovnikov addition of water and satisfactory 
yields of the aldehyde. However, these catalytic systems involve a high catalyst/metal loading and yield 
only moderate turnovers and selectivity. Using cyclopentadienyl ruthenium(II) complexes with 
monodentate or bidentate phosphine ligands provides an increased catalytic activity as well as 
selectivity towards the anti-Markovnikov product, e.g. [CpRu(dppm)Cl] (dppm = 
bis(diphenylphosphino)methane) gives the anti-Markovnikov product in excellent yield while tolerating 
a wide spectrum of substrates.20 
Nature uses proteins as polyfunctional ligands, which show multiple interactions between the enzyme 
and either substrate, intermediate(s), or transition state(s) during the catalytic cycle.3 For example, the 
tungsteno enzyme acetylene hydratase of Pelobacter acetylenicus uses acetylene as the sole carbon 
source, which is converted to acetaldehyde and then used by the enzyme to build acetic acid and 
ethanol, important building blocks for the bacteria’s metabolism.21,22,23,24 While enzymes are impressive, 
their structures are complex, and due to their high level of specificity for particular conversions, they 
are only of minor use for the development of generally efficient catalysts. 
More recently, phosphine ligands containing heterocyclic substituents such as pyridinyl or imidazolyl 
groups were investigated in bifunctional catalysis.25,26,27,2829 By modification of the pyridine ring the 
reactivity and catalytic activity of the corresponding complexes can be tuned.30 Grotjahn suggested that 
the nitrogen heterocycle acts as a bifunctional acid/base catalyst, initiating the protonation of the alkyne 
and leading to the ruthenium(IV) vinylidene species.31 
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In this report we investigated the hydration of terminal alkynes catalyzed by CpRu(II) compounds 
containing different imidazolyl phosphines as potentially bifunctional PN ligands. The imidazol-2-yl 
and imidazol-4-yl phosphine ligands employed bear substituents of varying steric demand. Also 
included were selected bis and tris(imidazolyl)phosphine ligands. 
2. Experimental Section 
2.1. Synthesis 
Compounds 1a,b,d – 3a,b,d32,33 and 1h34 as well as [CpRu(PPh3)2Cl]35 and [CpRu(C10H8)]PF636 were 
prepared according to literature procedures. All reactions were carried out in Schlenk tubes under an 
atmosphere of dry nitrogen using anhydrous solvents purified according to standard procedures. All 
chemicals were purchased from commercial sources and used as received. 1H and 31P NMR spectra 
were recorded on a Bruker DRX 200 spectrometer. The 1H spectra were calibrated against the residual 
proton signal of the solvent as an internal reference (CDCl3: δH = 7.30 ppm; methanol-d4: δH = 3.31 
ppm; acetone-d6: δH = 2.05 ppm, acetonitrile-d3: δH = 1.94 ppm) while the 31P{1H} NMR spectra were 
referenced to external 85% H3PO4. The ESI mass spectra were recorded on a Finnigan LCQ Deca ion 
trap API mass spectrometer. The MALDI mass spectra were recorded on a Bruker Ultraflex MALDI-
TOF mass spectrometer. The FAB mass spectra were recorded on a Finnigan MAT 8200 mass 
spectrometer using a nitrobenzylic alcohol (NBA) matrix. Infrared spectra were recorded with a Bruker 
IFS 66 FT-IR spectrometer. The elemental composition of the compounds was determined with a Perkin 
Elmer Analysator 2400 at the Institut für Pharmazeutische und Medizinische Chemie, Heinrich-Heine 
Universität Düsseldorf. 
2.1.1. Synthesis of 1-methyl-4,5-diphenylimidazole-2-yl-diphenylphosphine (2-MIPdiPh-NMe, 1c)  
1-Methyl-4,5-diphenylimidazole (2 g, 8 mmol) is placed in a Schlenk tube equipped with a magnetic 
stirring bar and dissolved in dry thf (100 mL). At –78 °C n-butyllithium (5.3 mL, 1.6 M in hexane) is 
added slowly to the solution, which turns deep red. The reaction mixture is stirred at –78 °C for 1 h until 
the diphenylchlorophosphine (1.6 mL, 8.0 mmol) is slowly added to the solution, which turns yellow 
and is then stirred over night at room temperature. The solvent is removed and the residue is dissolved 
in with ammonia-saturated dichloromethane. This solution is stirred over night and the white solid is 
filtered off. The solvent is removed from the filtrate yielding the product as a white-yellow solid, which 
is dried under vacuum. Yield 2.00 g (60 %). 1H NMR (200 MHz, CDCl3): δ = 3.57 (s, 3H, CH3), 7.15-
7.74 (m, 20H, Ph). 31P{1H} NMR (200 MHz, CDCl3): δ = –28.74 (s); ESI (methanol): m/z = 419 
[M++H], 341 [M+-Ph]; C28H23N2P·2/3CH2Cl2 (475.49): calc. C 72.5, H 5.2, N 5.9; found C 72.6, H 5.3, 
N 5.5. 
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2.1.3. Synthesis of 2-tert-butylimidazole-4(5)-yl-diphenylphosphine (4-MIPtBu, 1e) 
1-Methoxymethyl-2-tert-butylimidazole (1.3 g, 8.0 mmol) is placed in a Schlenk tube equipped with a 
magnetic stirring bar and dissolved in dry thf (100 mL). At –78 °C tert-butyllithium (5.3 mL, 1.6 M in 
hexane) is added slowly to the solution, which turns deep red. The reaction mixture is stirred at –78 °C 
for 1 h until the diphenylchlorophosphine (1.6 mL, 8.0 mmol) is slowly added to the solution, which 
turns yellow and is then stirred over night at room temperature. The solvent is removed and the residue 
is dissolved in with ammonia-saturated dichloromethane. This solution is stirred over night and the 
white solid is filtered off. The solvent is removed from the filtrate and the residue dissolved in 
acetone/water (10 : 1) and 2 mL of conc. hydrochloric acid added. The mixture is refluxed for 4 hours, 
all volatiles removed in vacuo and the residue dissolved in a minimum amount of ethanol and sodium 
hydroxide solution added. The precipitate is filtered off, washed with diethyl ether and dried in vacuo. 
Yield: 1.06 g (43 %). 1H NMR (200 MHz, CDCl3): δ = 1.34 (s, 9H, CH3), 6.91 Hz (s, Him), 7.25–7.35 
(m, 10H, Ph), 10.80 (very broad, 1H, NH). 31P{1H} NMR (81 MHz, CDCl3): δ = –31.0. ESI+ 
(methanol): m/z (%) = 309 [M+H]+ (100), 249 [M-tBu]+ (95). C19H21N2P·5/3H2O (308.36): calc. C 
67.44, H, 7.23, N 8.27; found C 67.49, H 6.90, N 8.14. 
2.1.4. Synthesis of 2-phenylimidazole-4(5)-yldiphenylphosphine (4-MIPPh, 1f) 
1-Methoxymethyl-2-phenylimidazole (1.5 g, 8.0 mmol) is placed in a Schlenk tube equipped with a 
magnetic stirring bar and dissolved in dry thf (100 mL). At –78 °C tert.-butyllithium (5.3 mL, 1.6 M in 
hexane) is added slowly to the solution, which turns deep red. The reaction mixture is stirred at –78 °C 
for 1 h until the diphenylchlorophosphine (1.6 mL, 8.0 mmol) is slowly added to the solution, which 
turns yellow and is then stirred over night at room temperature. The solvent is removed and the residue 
is dissolved in with ammonia-saturated dichloromethane. This solution is stirred over night and the 
white solid is filtered off. The solvent is removed from the filtrate and the residue (which is the 
protected phosphine, 1H NMR (200 MHz, CDCl3): δ = 3.23 (s, 3H, OCH3), 5.40 (d, J = 1.5 Hz, CH2), 
6.86 Hz (s, Him), 7.33–7.85 (m, 15H, Ph). 31P{1H} NMR (81 MHz, CDCl3): δ = –34.0) dissolved in 
acetone/water (10 : 1) and 2 mL of conc. Hydrochloric acid added. The mixture is refluxed for 4 hours, 
all volatiles removed in vacuo and the residue dissolved in a minimum amount of ethanol and sodium 
hydroxide solution added. The precipitate is filtered off, washed with diethyl ether and dried in vacuo. 
Yield: 1.39 g (53 %). 1H NMR (200 MHz, CDCl3): δ = 6.71 Hz (s, 1H, Him), 7.15–8.00 (m, 15H, Ph) 
8.44 (s, 1H, Him), 15.17 (s, broad, 1H, NH). 31P{1H} NMR (81 MHz, CDCl3): δ = –29.8. ESI MS 
(methanol): m/z (rel. int.) = 386 (100) [M+NaCl]+, 329 (15) [M+H]+. C21H17N2P·C2H5OH (374.42): 
calc. C 73.78, H, 6.19, N 7.48; found C 73.85, H 5.50, N 7.02. 
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2.1.5. Synthesis of 1-methyl-2-isopropylimidazole-4-yldiphenylphosphine (4-MIPiPr,NMe, 1i) 
1-Methyl-4-iodo-2-isopropylimidazole (1 g, 4 mmol) is dissolved in dichloromethane. One equivalent 
of ethyl magnesium bromide (3 M in ether) is slowly added to the solution at 0 °C. The clear solution is 
stirred for 30 min at room temperature before the diphenylchlorophosphine (0.75 mL, 4.0 mol [are 
0.75ml really 4 mol??]) is added. The solution is stirred at room temperature over night. The solvent is 
removed and the soft solid is redissolved in ammonia-saturated dichloromethane and stirred over night. 
A white solid precipitates which is filtered off. The solvent of the filtrate is removed, yielding a white-
yellow solid, which is then stirred in ethanol under addition of 1 mL of hydrochloric acid. The solvent is 
removed and the solid stirred in ammonia-saturated dichloromethane. The precipitated white solid is 
removed by filtration and the solvent of the filtrate is removed, resulting in a white powder, which is 
dried under vacuum. Yield 0.71 g (58 %). 1H NMR (200 MHz, methanol-d4): δ = 1.34 (d, 6H, CH3), 
3.19 (m, 1H, CH), 3.63 (s, 3H, CH3), 6.56 (s, 1H, CH), 7.36-7.84 (m, 10H, Ph); 31P{1H} NMR (81 
MHz, methanol-d4): δ = –24.44 (s); EI MS (methanol): m/z = 308 [M+]. C19H21N2P·H2O (326.15): calc. 
C 66.50, H 6.70, N 9.83; found C 66.88, H 6.68, N 10.04. 
2.1.6. Synthesis of 1-methyl-2-tert-butylimidazole-4-yldiphenylphosphine (4-MIPtBu,NMe, 1j) 
1-Methyl-4-iodo-2-tert-butylimidazole (1.2 g, 45 mmol) is dissolved in dichloromethane. One 
equivalent of ethyl magnesium bromide (3 M in ether) is slowly added to the solution at 0 °C. The clear 
solution is stirred for 30 min at 0°C and another 30 min at room temperature before the diphenylchloro 
phosphine (0.82 mL, 4.5 mol [see question above]) is added. The solution is stirred at room temperature 
over night. The solvent is removed and the solid is redissolved in ammonia-saturated dichloromethane 
and stirred over night. A white solid precipitates which is filtered off. The solvent of the filtrate is 
removed, yielding a white-yellow solid, which is then stirred in ethanol under addition of 1 mL of 
hydrochloric acid. The solvent is removed and the solid stirred in ammonia-saturated dichloromethane. 
The precipitated white solid is removed by filtration and the solvent of the filtrate is removed, resulting 
in a white powder, which is dried under vacuum. The solid is recrystallized from acetone and dried 
under vacuum. The product was yielded as MgBr2 adduct. Yield 0.88 g (42 %). 1H NMR (200 MHz, 
CDCl3): δ = 1.67 (s, 9H, CH3), 3.91 (s, 3H, CH3), 6.34 (s, 1H, CH), 7.42-8.09 (m, 10H, Ph). 31P{1H} 
NMR (81 MHz, CDCl3): δ = –30.48 (s). MS ESI (methanol): m/z = 527 [LMgBr2 + Na]+ (15). 
C20H23N2PMgBr2NH3 (523.53): calc. C 45.88, H 5.01, N 8.03; found C 45.15, H 5.75, N 7.65. 
2.1.7. Synthesis of imidazole-2-yl-phenylphosphine (2-BIPH, 2a) 
A solution of n-butyl lithium in n-hexane (1.6 M, 12 mL, 19 mmol) was added drop-wise to a solution 
of 3.0 g (18 mmol) of 1-diethoxymethylimidazole in diethyl ether (150 mL) at –78°C. The reaction 
mixture was stirred at –40°C for 1 h and then was cooled to –78°C and PCl3 (1.56 g, 8.72 mmol) was 
 6
added. The reaction mixture was stirred at –78°C for 1h and at ambient temperature over night. 
Concentrated ammonia solution (5 mL) was added, the phases separated, the organic phase was 
collected and all volatiles were removed in vacuo. The oily residue was dissolved in 100 mL 
acetone/water (10:1) and stirred at ambient temperature for 72 h. The resulting precipitate was collected 
by filtration and dried in vacuo. Yield: 1.1 g (52 %). 1H NMR (methanol-d4): δ = 7.27 – 7.35 (m, 9H). 
31P{1H} NMR (methanol-d4): δ  = –46 (s). ESI+ (methanol): m/z (%) = 243 [L]+. C12H11N4P·CH3OH 
(274.26): calc. C 56.93, H 5.51, N 20.43; found C 56.4, H 5.6, N 20.7.  
2.1.8. Synthesis of [CpRu(P-1d)(PPh3)Cl] (4) 
[CpRu(PPh3)2Cl] (0.5 g, 0.69 mmol) and 1d (0.17 g, 0.67 mmol) were heated for 4 h in toluene to 
reflux. The volatiles were removed in vacuo and the residue treated with n-hexane to give a yellow 
solid. After filtration the product was chromatographed on silica (CH2Cl2:n-hexane 3:1, followed by 
CH2Cl2). Yield 52 mg (10 %).  1H NMR (200 MHz, CDCl3): δ = 1.20 (dd, 3JHH = 6.9 Hz, 3JHH = 12.9 
Hz, 6H, CH(CH3)2), 2.77 (m, 1H, CH(CH3)2), 4.22 (d, 3JHH = 9.3 Hz, 5H, Cp), 6.72 (s, 1H, Im), 6.98 – 
7.24 (m, 15 H, PPh3), 7.26 – 7.83 (m, 11H, Ph). 31P{1H} NMR (81 MHz, CDCl3): δ = 45.0 (dd, 2JPP = 
28.3 Hz, 43.0 Hz), 30.4 (t, 2JPP = 21.3 Hz). MALDI-TOF-MS: m/z (rel. Int.) = 755 [M-2H]+ (25), 723 
[M-Cl]+ (100), 461 [M-PPh3Cl]+ (25). C41H39ClN2P2Ru (758.29): calc. C 65.0, H 5.2, N 3.7; found C 
65.1, H 4.9, N 3.7. 
2.1.12. Synthesis of [CpRu((P-1a)2Cl] (5) 
[CpRu(PPh3)2Cl] (100 mg, 0.138 mmol) and 1a (70 mg, 0.28 mmol) were heated to 90 °C for 8 hours in 
toluene (15 mL). The volatiles were removed in vacuo and the residue treated with n-hexane (15 mL). 
The resulting solid was filtered and dried in vacuo. Yield 61 mg (63 %). 1H NMR (200 MHz, CDCl3): δ 
= 4.38 (s, %H, Cp), 3.44 (br, NH), 6.93 (s, 2H, im), 9.09-7.60 (m, 22H, Ph,im). 31P{1H} NMR (81 
MHz, CDCl3): δ = 31.7 (s). MALDI-TOF-MS: m/z (rel. Int.) = 671 [M-Cl]+ (100), 460 [M-1a-Cl]+ (25). 
 C35H31N4P2ClRu (706.13): calc. C 59.5, H 4.4, N 7.9; found C 60.0, H 4.6, N 8.1. 
2.1.8. Synthesis of [CpRu(P-1d)2Cl] (6) 
[CpRu(PPh3)2Cl] (0.51 g, 0.70 mmol) and 1d (0.38 g, 1.5 mmol) were heated for 20 h in toluene to 
reflux. The volatiles were removed in vacuo and the residue treated with n-hexane to give a yellow 
solid. After filtration the product was chromatographed on silica (ethyl acetate). Crystallization from 
methanol/n-hexane yielded 18 mg (30 %) of 6.  1H NMR (200 MHz, CDCl3): δ = 1.28 (dd, 3JHH = 6.9 
Hz, 14.1 Hz, 12H, CH(CH3)2), 2.85 (sept, 2H, 3JHH = 6.9 Hz, CH(CH3)2), 4.27 (s, 5H, C5H5), 6.75 (s, 
2H, ImC5H), 7.06 – 7.28 (m, 10H, Ph), 7.35 – 7.80 (m, 10H, Ph), 11.0 (s, 2H, ImNH). 31P{1H} NMR 
(81 MHz, CDCl3): δ = 26.4 (s). MALDI-TOF-MS: m/z (rel. Int.) = 755 [M-Cl]+ (100), 461 [M-1d-Cl]+ 
(25). C41H43N4P2ClRu (790.29): calc. C 62.3, H 5.5, N 7.1; found C 62.6, H 5.1, N 7.4. 
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2.1.8. Synthesis of [{CpRu(-2N,N:’1P-2a)}2](PF6)2 (7a) 
50 mg (0.12 mmol) of [CpRu(NCCH3)3]PF6 and 2a (0.12 mmol, 36 mg) were dissolved in acetonitrile 
and heated to gentle reflux for 24 hours. The volatiles were removed in vacuo, the residue washed with 
n-hexane and diethyl ether and dried in vacuo. Yield: 69 mg (90 %).1H NMR (500 MHz, acetonitrile-
d3): δ = 3.09 (s, 12H NCH3), 5.23 (s, 5H Cp), 6.79 (s, 2H arom. Im), 6.95 (t, 3JH,H = 8.2 Hz, 1H Ph), 
7.13 (s, 2H arom. Im.), 7.40 (t, 3JH,H = 7.6 Hz, 1H Ph), 7.65 (t, 3JH,H = 7.4 Hz, 1H Ph), 7.75 (t, 3JH,H = 
7.0 Hz, 1H Ph), 8.23 (t, 3JH,H = 9.6 Hz, 1H Ph) 31P{1H} NMR (81 MHz, acetonitrile-d3): δ = 45.4 (s), –
142.7 (sept., 1JPF = 707 Hz). ESI MS (methanol): m/z (rel. int.) = 437 (100) ½ [M+H]+, 355 (15) ½ [M-
ImNMe]+. MALDI-TOF-MS (methanol): m/z (rel. int.) = 437 (100) [M]+. C38H40N8F12P4Ru2 (1162.81) 
calc. C 39.3, H 3.5, N 9.6; found C 39.6, H 3.9, N 10.0. 
2.1.9. Synthesis of [{CpRu(-2N,N:’1P-2b)}2](PF6)2 (7b) 
50 mg (0.12 mmol) of [CpRu(NCCH3)3]PF6 and 2a (36 mg) were dissolved in acetonitrile and heated to 
gentle reflux for 24 hours. The volatiles were removed in vacuo, the residue washed with n-hexane and 
diethyl ether and dried in vacuo. Yield 46 mg (67 %). 1H NMR (acetonitrile-d3): δ = 4.91 (s, 5H Cp), 
6.95 (s, 2H ImCH), 6.99 (s, 2H ImCH), 7.58 – 7.80 (m, 5H PPh). 31P{1H} NMR (acetonitrile-d3): δ = 
44.4 (s), –143.4 (hept.). MALDI-TOF-MS (CH3CN): m/z (rel. int.) = 816 [M]+ (100), 574 (5), 468 (45), 
453 [½ M+NCCD3]+ (30), 409 [½ M]+ (80). C36H35N9P4Ru2F12 (1147.75): calc. C 37.7,H 3.1, N 11.0; 
found C 37.5, H 3.2, N 10.7. 
2.1.10. Synthesis of [CpRu(3N,N,N-3b)]Cl (8) 
100 mg (0.138 mmol) of [CpRu(PPh3)2Cl] were dissolved in warm toluene. To the clear orange solution 
3a (38 mg, 0.14 mmol) was added. The solution was warmed to 100 °C and after 30 min. a yellow solid 
precipitated. The reaction mixture was stirred at 100 °C for additional 3 hours. After cooling to ambient 
temperature and filtration the solid was washed with small amounts of toluene and diethyl ether and 
dried in vacuo. Yield: 51 mg (78 %). 1H NMR (200 MHz, methanol-d4): δ = 4.06 (s, 9H, NCH3), 4.50 
(s, 5H, Cp), 7.38 (dd, 3JH,H= 4.0 Hz, 4JH,H= 1.6 Hz, 3H, ImH5), 7.99 (s) (d, 3JH,H= 4.0 Hz, 3H, ImH4). 
31P{1H} NMR (81 MHz, methanol-d4): δ = –116.5 (s). MALDI TOF MS: m/z (rel. Int.) = 441 [M-Cl]+ 
(100). C17H22N6ClPRu·H2O (493.90): calc. C 41.4, H 4.5, N 17.0; found C 41.7, H 4.7, N 16.7. 
2.1.11. Synthesis of [CpRu(P-3a)(PPh3)Cl] (9) 
100 mg (0.132 mmol) [CpRu(PPh3)2Cl] were dissolved in 20 mL toluene upon gentle heating. 32 mg 
(0.13 mmol) of 3a were added and the solution was stirred at 70 °C for 6 h. A greenish white solid was 
separated and the orange solution was subsequently reduced in vacuo. The orange residue was taken up 
in 2 mL dichloromethane. Column-chromatography on silica gel with dichloromethane and ethyl acetate 
respectively, gave the product as an orange solid. Yield: 55 mg (57 %) 1H NMR (200 MHz, methanol-
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d4): δ = 4.54 (s, 5H, Cp), 7.08–7.34 (m, 21H, arom.). 31P{1H} NMR (81 MHz, methanol-d4): δ = 46 (d, 
2JP,P = 45 Hz), 4 (d, 2JP,P = 45 Hz). ESI MS (methanol): m/z (rel. int.) = 399 (100) [M-PPh3Cl]+. MALDI 
TOF MS (methanol): m/z (rel. int.) = 399 (60) [M-PPh3Cl]+, 415 (15) [CpRu(2-TIPOH)]+. 
C32H31N6ClP2Ru·2H2O (732.12): calc. C 52.5, H 4.5, N 11.5; found C 52.3, H 4.6, N 11.4. 
2.2. General procedure for the catalytic hydration reaction 
[RuCp(C10H8)]PF6 (22 mg, 0.05 mmol) and the respective ligand (2.2 eq., 0.11 mmol) were dissolved in 
acetonitrile or dichloromethane, respectively. The solution was stirred at 60 °C over night. Removal of 
most of the solvent under vacuum and addition of diethyl ether or hexane resulted in the respective 
ruthenium complex as a fine yellow powder, which is dried under vacuum after filtration. This 
preformed, but not further purified ruthenium catalyst (0.05 mmol, 5 mol% catalyst loading) was 
dissolved in acetone (2 mL) and degassed 1-octyne (150 µL) and water (90 µL) were added to the 
solution. The reaction mixture was stirred at 60 °C in an oil bath. The progress of the reaction was 
monitored by GC. 
2.3. X-ray crystallography 
Crystallographic data of [{CpRu(-2-N,N-’1-P-2b)}2](C6H5PO3H)2(C6H5PO3H2)2, 
[{CpRu(2b)}2](PF6)2.2CH3CN (7b.2CH3CN), [CpRu(1a)2Cl].H2O (5.H2O) and [CpRu(PPh3)2Cl]·CHCl3 were 
collected at 183(2) K on an Oxford Diffraction Xcalibur system with a Ruby detector using Mo Kα radiation (λ = 
0.7107 Å) that was graphite-monochromated. Suitable crystals were covered with oil (Infineum V8512, formerly 
known as Paratone N), mounted on top of a glass fibre and immediately transferred to the diffractometer. The 
program suite CrysAlisPro was used for data collection, multi-scan absorption correction and data reduction.37 
Structures were solved with direct methods using SIR9738 and were refined by full-matrix least-squares methods 
on F2 with SHELXL-97.39 The structures were checked for higher symmetry with help of the program Platon.40 
The crystal of [{CpRu(2b)}2](PF6)2.2CH3CN (7b.2CH3CN) is non-merohedrally twinned. The two twin domains 
are related by a 180  degree rotation along uvw (0 0 1). Both domains (ratio 52:48) were integrated with the 
CrysalisPro software and refined as hklf5. Yellow crystals of 5.H2O were mounted on a glass fibre with a 
small amount of inert oil. Data collection was carried out at 100 K using an Oxford Diffraction Xcalibur 
diffractometer, equipped with an EOS CCD area detector and a four-circle kappa goniometer using Mo-
Kα radiation (λ = 0.71073 Å). Data integration, scaling and empirical absorption correction was carried 
out using the CrysAlis Pro program package.37 The structure of was solved using Direct Methods and 
refined by Full-Matrix-Least-Squares against F2. All non-hydrogen atoms positions were refined freely 
and simultaneously using anisotropic displacement parameters. The positional parameters of the 
hydrogen atoms of the CH groups were refined freely. The positional parameters of the hydrogen atoms 
of the NH groups were refined with soft N─H distance restraints and individual Uiso values. The 
hydrogen atoms of the water molecule were refine with soft O-H and H-H distance restraints giving 
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these hydrogen atoms a fixed isotropic displacement parameters. All calculations were carried out using 
the program SHELX97.  Orange crystals of [CpRu(1P-3a)(PPh3)]Cl·CH2Cl2 (9.CH2Cl2) were mounted on a 
MiTeGen cryoloop with a small amount of inert oil. Data collection was carried out at 150 K using an Oxford 
Diffraction Gemini E Ultra diffractometer, equipped with an EOS CCD area detector and a four-circle kappa 
goniometer using Mo-Kα radiation (λ = 0.71073 Å). Data integration, scaling and empirical absorption correction 
was carried out using the CrysAlis Pro program package.37 The structure was solved using Direct Methods and 
refined by Full-Matrix-Least-Squares against F2. All non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were placed at idealised positions and refined using the riding model. All calculations were 
carried out using the program Olex2.41 Important crystallographic data and refinement details are summarised in 
Table 4. The crystallographic data has been deposited at the CCDC with the ref codes CCDC 820763, 828860, 
828861, and 837344. 
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3. Results and Discussion 
3.1. Synthesis of PN ligands 
Pyridin-2-ylphosphines are privileged hemilabile PN ligands in transition metal catalysis. Also, 
imidazole-2-ylphosphines are well-established ligands for transition metal complexes, e.g. Grotjahn et 
al. recently described the ability of imidazole-2-yldiphenylphosphine to act as a hemilabile PN ligand in 
Cp*Ir complexes42 and Caballero et al. observed rearrangement of 1-methylimidazole-2-
yldiphenylphosphine (1b) in complexes [(arene)Ru(1b)Cl2] including P–C bond cleavage in this 
process.43 We synthesised several series of imidazole-based phosphine ligands in the last few years for 
biomimetic model complexes and metallo-drugs.33,34,44,45,46,47 Here, these ligands as well as some new 
PN ligands, as depicted in Figure 1, were used in CpRu-complexes, which should catalyse the hydration 
of alkynes.  
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N
N
N
N
N Ph
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R' = H; R'' = i-Pr (1d), t-Bu (1e), Ph (1f)
R' =Me; R'' = H (1h), i-Pr (1i), t-Bu (1j)
R'
PhP
N
R
N
2
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N
R
N
3
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3i-Pr
PhP
N
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2i-Pr
1a 1b 1c
R = H (2a)
R = Me (2b)
R = H (3a)
R = Me (3b)
2d 3d
 
Figure 1. Imidazol-2-yl- and imidazol-4-yl-phosphine ligands used. 
Especially imidazole derivatives with bulky groups such as isopropyl, phenyl or tert-butyl in ortho-
position to the imine N atom were chosen since they are known to prevent κ2PN-coordination.30 
Furthermore, ligands without sterically demanding groups such as 1-methylimidazole-4-yldiphenyl 
phosphine (1h) were synthesized. 
The reaction scheme for the synthesis of the new imidazol-4-yl phosphine ligands 1h-j is shown in 
Scheme 1. The respective imidazole is converted to the 4,5-diiodoimidazole derivative by KI/I2 in basic 
solution. Reaction of the 4,5-diiodoimidazole derivative with methyl iodide leads to the N-methylated 
imidazole derivative, which is then converted in two consecutive Grignard reactions to the respective 1-
methylimidazol-4-yldiphenyl phosphine. 
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Scheme 1. General route for the synthesis of 1-methylimidazol-4-yldiphenylphosphines 1h-j (4-
MIPNMe’s), i) I2/KI in aq. NaOH, ii) KOtBu, MeI, thf, iii) EtMgBr, H2O, thf, iv) EtMgBr, Ph2PCl, thf. 
All steps, including the first Grignard reaction, proceed in good yields, whereas the second Grignard 
reaction raised some problems. The product was obtained as the magnesium complex, since magnesium 
coordinates strongly to the imidazole N atom(s). This problem of magnesium adduct formation has 
already been addressed by Kluwer in the preparation of pyridinylphosphines.48 Repeated alternating 
stirring in ethanol, spiked with hydrochloric acid, or ammonia-saturated dichloromethane led to 
isolation of the ligands 1-methylimidazol-4-yldiphenylphosphine (1h) and 1-methy-2-
isopropylimidazole-4-yldiphenylphosphine (1i). In the case of 1-methyl-2-tert-butylimidazole-4-
yldiphenylphosphine (1j), even after repeated crystallisation from ethanol, the MgBr2 adduct was 
obtained.  
In addition to the three 1-methylimidazol-4-yl phosphine ligands 1h-j, 1-methyl-4,5-diphenylimidazol-
2-yl-diphenylphosphine (1c) was synthesized as a new imidazole-2-yl ligand bearing bulky phenyl 
substituents (Scheme 2). The methylation of 4,5-diphenylimidazol is carried out using methyl iodide. 
Subsequent lithiation with n-butyllithium and addition of diphenylchlorophosphine leads to the 1-
methyl-4,5-diphenylimidazol-2-yl-diphenylphosphine ligand in very good yields. Since lithium does not 
coordinate as strongly to the imidazole nitrogen atoms as magnesium, the separation of the lithium salts 
from the ligand is easily accomplished by stirring the crude product with ammonia-saturated 
dichloromethane followed by filtration. 
H
N
N
Ph
Ph
N
N
Ph
Ph
i) N
N
Ph
Ph
PPh2
ii)
 
Scheme 2. Route for the synthesis of 1-Methyl-4,5-diphenylimidazol-2-yl-diphenylphosphine (2-
MIPdiPhNMe, 1c): i) KOtBu, MeI, thf, ii) n-BuLi, Ph2PCl, thf. 
Spectroscopic data of the four new ligands 1c,h-j is summarized in Table 1. The chemical shifts 
observed in the 31P NMR spectra are in the typical regime for monoimidazolyldiphenyl phosphines 
(MIPs). 45,49  
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Table 1.Spectroscopic data of the synthesized ligands (a in methanol-d4, b in CDCl3, c Mg-salt). 
Ligand  δ(1H) / ppm δ(31P) / ppm 
4-MIPNMe (1h) a 3.73 (s, 3H, CH3), 6.93 (t, 1H, CH),  
7.31-7.42 (m, 10H, Ph), 7.80 (t, 1H, CH) 
–22.8 (s) 
4-MIPiPr,NMe (1i) a 1.34 (d, 6H, CH3), 3.19 (m, 1H, CH),  
3.63 (s, 3H, CH3), 6.56 (s, 1H, CH), 
7.36-7.84 (m, 10H, Ph) 
–24.4 (s) 
4-MIPtBu,NMe  (1j) b 1.67 (s, 9H, CH3), 3.91 (s, 3H, CH3),  
6.34 (s, 1H, CH), 7.42-8.09 (m, 10H, Ph) 
–30.4 (bs)c 
2-MIPdiPh,NMe  (1c) b 3.57 (s, 3H, CH3), 7.15-7.74 (m, 20H, Ph) –28.7 (s) 
 
3.2. Synthesis of CpRu-complexes with PN ligands 
We exemplarily investigated the basic coordination chemistry of some of the presented imidazole-based 
PN ligands towards CpRu(II). As ruthenium(II) precursor compounds we used [CpRu(C10H8)]PF6, 
[CpRu(NCMe)3]PF6 and [CpRu(PPh3)2Cl] (Scheme 3). 
Ru
Ph3P Cl
PPh3 RuL
Cl
PPh3 RuL
Cl
L
Ru
H3CCN NCCH3
NCCH3 PF6
L L
Ru PF6or Ru
L
NCCH3
L
L
PF6CH3CN
 
Scheme 3. Reaction of ligands (L) 1a, 1b and 1d with [CpRu(PPh3)2Cl] and [CpRu(NCCH3)3]PF6 or 
[CpRu(C10H8)]PF6. 
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Table 2. 31P{1H} NMR shifts of the ligands (δL) and the respective ruthenium complexes (δC) as well as 
the coordination shift Δδ = δC –δL (in methanol-d4). 
CpRu(PPh3)(L)Cl δL(31P)/ppm δC(31P)/ppm Δδ(31P)/ppm 
2-MIPH (1a) –23.8 45.0; 29.3 68.8 
2-MIPNMe (1b) –29.6 42.5; 27.6 64.3 
4-MIPiPr (1d) –24.4 45.0; 30.4 73.0 
CpRu(L)2PF6 δL(31P)/ppm δC(31P)/ppm Δδ(31P)/ppm 
2-MIPH (1a) –24.8 31.7 56.5 
2-MIPNMe (1b) –30.6 29.3 60.0 
4-MIPiPr (1d) –24.4 31.3 55.7 
When [CpRu(PPh3)2Cl] was reacted with 1b at room temperature for three weeks, only one PPh3 ligand 
was replaced by 1b yielding [CpRu(PPh3)(1b)Cl], as is indicated by two doublets in the 31P NMR 
spectrum (
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Table 2). These appeared only in small quantities in addition to signals of the starting materials and free 
triphenylphosphine. However, reaction of 1b with the more labile complex [CpRu(NCCH3)3]PF6 in 
dichloromethane yielded the complex [CpRu(1b)2(solvent)]PF6 which exhibits a single singlet in the 31P 
NMR spectrum at 38 ppm. Both 1H NMR and MALDI mass spectra are also in accordance with the 
proposed formula. The reaction of two equivalents of 1a with [CpRu(PPh3)2Cl] below 70 °C in toluene 
gives [CpRu(1a)2Cl] (5) by substitution of both PPh3 ligands (singlet, δ(31P) = 31.7 ppm). Minor 
contamination of the mono-substituted complex (doublet, δ(31P) = 45.0, 29.3 ppm, J = 44 Hz) ligands  
were transformed into [CpRu(1a)2Cl] (5) by addition of a slight excess of 1a. When the reaction 
mixtures of [CpRu(PPh3)2Cl] and the NH-ligand 1a were heated above 90 °C, doublets at 120 and 50 
ppm in the 31P{1H} NMR spectra were observed. The reaction with one or two equivalents of 1d gives 
[CpRu(PPh3)(1d)Cl] (4) and [CpRu(1d)2Cl] (6), respectively. For the latter we were not able to obtain a 
sufficient CHN analysis, although 1H and 31P{1H} NMR and MALDI-TOF mass spectrometry clearly 
demonstrate the existence of [CpRu(1d)2Cl] (6). The compound [CpRu(PPh3)(1d)Cl] (4) shows, as 
expected, two signals in the 31P NMR spectrum. In non-coordinating or weakly coordination solvents 
the resonances are found at 45 and 25 ppm with a 2JPP coupling constant of 43 Hz. In the more strongly 
coordination solvent methanol, which is a good solvent for the solvation of chloride, the resonances are 
shifted to 53 and –5 ppm with a coupling constant of 39 Hz (Table 3). Especially the high field shift of 
the resonance of the P-atom of the ligand 1d from about 25 to –5 ppm is typical for the change in the 
coordination mode of the ligand from κP to κ2PN.50 This can also be forced in acetone by abstraction of 
the chloride ligand upon addition of TlNO3 (Scheme 4 and ESI). 
Table 3. 31P{1H} NMR data of [CpRu(PPh3)(1d)Cl] (4) in different solvents. 
Solvent δPPh3(31P) / ppm 2JPP / Hz δ1d(31P) / ppm 2JPP / Hz 
C6D6 45.8 43 25.3 43 
CDCl3 44.1 43 26.1 43 
(CD3)2CO 44.4 43 23.8 43 
CD3OD 52.8 39 –5.1 39 
Ru
Ph2P N
N
H
iPr
PPh3
Ru
Ph2P Cl
PPh3
HN
N
iPr
+ Tl+, – TlCl
acetone
 
Scheme 4. Reaction of [CpRu(PPh3)(1d)Cl] (4) with TlNO3 in acetone gives a PN chelate. 
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The reaction of 2a with [CpRu(PPh3)2Cl] or [CpRu(NCCH3)3]PF6 gave a single product with a singlet at 
45 ppm in the 31P{1H} NMR spectrum and one set of the protons of the methyl groups (singlet at 3.09 
ppm), the Cp protons (singlet at 5.23 ppm) and the imidazolyl protons (two doublets at 6.79 and 7.13 
ppm) in the 1H NMR, respectively. The most intense signal in the MALDI spectrum is found at m/z = 
437 and shows an isotopic pattern characteristic for a compound with two ruthenium atoms and thus a 
charge of +2. Additionally, a peak with small intensity is found at 874. This is in accordance with a 
dimeric structure (Scheme 5), which was confirmed by single crystal analysis (see below). 
P
N
R
N
3
[CpRu(PPh3)2Cl] or
[CpRu(NCCH3)3]PF6 NRu P
N
RuP
N
R
R
N
Ph
Ph
2 2
(X)2
 
Scheme 5. Reaction of [CpRu(PPh3)2Cl] or [CpRu(NCCH3)3]PF6 with 2-BIPNH (2a) and 2-BIPNMe (2b) 
to complexes 7a/b (X = PF6). 
The tripodal tetradentate ligands 3a and 3b react with [CpRu(PPh3)2Cl] at elevated temperatures and 
prolonged reaction times to complexes in which the CpRu-moiety is facially bound by the tripodal 
ligands in a 3N,N,N coordination mode (Scheme 6). The coordination mode can be deduced by the 
typical high-field shift of the phosphorus resonance of 40 to 60 ppm to about –110 ppm in 3N,N,N 
complexes of these ligands. 
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Scheme 6. Reaction of [CpRu(PPh3)2Cl] with 2-TIPNH (R = H, 3a) and 2-TIPNMe (R = Me, 3b). 
At 70 °C and in the non-protic solvent toluene the reaction of 3a with [CpRu(PPh3)2Cl] leads to 
substitution of only one PPh3 ligand, which can easily be observed in the 31P NMR spectra of the 
reaction mixture. Two doublets occur for the new species [CpRu(PPh3)(3a)Cl] (9) with 2JP,P values of 
~50 Hz. This product is also obtained from a reaction of the starting material with 2 equivalents of 
ligand 3a. Recrystallisation from chloroform yielded a crystal suitable for single crystal analysis (see 
below).  
3.3. Solid-state structures 
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Crystals of [CpRu(1a)2Cl].H2O (5.H2O) suitable for single crystal structure determination were 
obtained by slow evaporation of a chloroform solution at air. The CpRu center is coordinated octahedral 
by the η5-Cp ligand, a chlorido ligand and two P-coordinated ligands 1a. Both ligands 1a form NH…Cl 
hydrogen bonds towards the coordinated chlorido ligand and one is also involved in hydrogen bonding 
to the co-crystallised water molecule. The structural motif in [CpRu(1a)2Cl].H2O (5.H2O) resembles the 
one found in [CpRu(L)2(H2O)]CF3SO3 (L = 1-methyl-3-tert.butyldiphenyl phosphine).28 
 
Figure 2. Solid-state structure of [CpRu(1a)2Cl]·H2O (5.H2O). Displacement ellipsoids are drawn at 50 
% level. Hydrogen atoms are drawn at arbitrary radius and non-acidic hydrogen atoms are omitted for 
clarity. 
Crystals of [{CpRu(-2N,N:1P-2b)}2](PF6)2.CH3CN (7b.CH3CN) suitable for single crystal 
structure determination were obtained by slow diffusion of n-hexane into a solution of 7b in 
acetonitrile. Here ligand 2b acts as bridging ligand between two CpRu centers (Figure 3). Such a 
bridging -2N,N:1P-coordination mode has tentatively been assigned to the phenylbis(pyridin-2-
yl)phosphine ligand (PhPpy2) in the compound [Mo(CO)3(PhPpy2)], which is thought to be a 
coordination polymer and not a cyclic dimer.51 In the [{CpRu(-2N,N:1P-2b)}2]2+ cation the 
coordination geometry of the Ru(II) atoms in the {CpRu(2b)} unit is distorted octahedral with a facially 
bound η5-Cp ligand and the P atom of the 2b ligand as well as two N atoms of the 2b ligand of the other 
unit of the {CpRu(2b)}2 dimer. In one crystallisation experiment under non inert conditions from the 
reaction solution of [CpRu(PPh3)2Cl] together with 2b, we found yellow crystals of [{CpRu(μ - κ 2-
N,N- κ’1-P-2b)}2](C6H5PO3H)2(C6H5PO3H2)2 which crystallized in the triclinic space group P-1 (see 
ESI). Additionally, we found red crystals of a chloroform solvate of [CpRu(PPh3)2Cl] which crystallises 
in the triclinic space group P-1 (see ESI). Obviously, 2b partially hydrolysed under P-C bond cleavage 
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and oxidized to give the phenylhydrogenphosphonate counter ion and the 
phenyldihydrogenphosphonate respectively. Both structures have essentially an identical cationic part. 
Only the cyclopentienyl and the phenyl ring are conformational slightly twisted along the ruthenium - 
cyclopentadienyl centroid and the ispo - para atoms of the phenyl ring respectively. 
 
Figure 3. Solid-state structure of the cation [{CpRu(-2-N,N-’1-P-2b)}2]2+ in [{CpRu(μ - κ 2-N,N- 
κ’1-P-2b)}2](PF6)2.CH3CN (7b.CH3CN). Displacement ellipsoids are drawn at 50 % level. The counter 
ions, cocrystallized solvent molecules and hydrogen atoms are omitted for clarity.  
Red crystals of  [CpRu(1P-3a)(PPh3)]Cl·CH2Cl2 (9·CH2Cl2) were obtained by crystallisation from 
chloroform. The compound crystallizes in the monoclinic space group P21/c. Two of the three H atoms 
of the NH-functionalities of the ligand 3a form intramolecular hydrogen bonds towards Cl1. Another 
intramolecular hydrogen bond N-HA…N1AA results in the formation of a nearly coplanar six-membered 
ring (Figure 4). The metric parameters are within the range found in phosphine complexes of the type 
[CpRu(L)2Cl].52,53,54,55 
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Figure 4. Solid-state structure of [CpRu(1P-3a)(PPh3)]Cl·CH2Cl2 (9·CH2Cl2). Displacement ellipsoids 
are drawn at 50 % level. Hydrogen atoms are drawn at arbitrary radius and non-acidic hydrogen atoms 
are omitted for clarity. 
Table 4. Crystallographic data for [CpRu(1a)2Cl]·H2O (5.H2O), [{CpRu(μ - κ 2-N,N- κ’1-P-
2b)}2](PF6)2.CH3CN (7b.CH3CN), [{CpRu(μ - κ 2-N,N- κ’1-P-2b)}2](C6H5PO3H)2(C6H5PO3H2)2,  
[CpRu(1P-3a)(PPh3)]Cl·CH2Cl2 (9·CH2Cl2) and [CpRu(PPh3)2]Cl·CHCl3. 
Compound 5.H2O 7b.CH3CN 
 
[{CpRu(2b)}2] 
(C6H5PO3H)2(C6H5PO3H2)2 
9·CH2Cl2 [CpRu(PPh3)2]Cl 
·CHCl3 
Empirical formula  C35H33ClN4OP2Ru C42H46F12N10P4Ru2 C62H66N8O12P6Ru2 C33H31Cl3N6P2Ru C42H36Cl4P2Ru
Formula weight  724.11 1244.91 1503.19 781.00 845.52
Crystal system  Monoclinic Monoclinic Triclinic Monoclinic Triclinic
Space group  P21/n P21/c P-1 P21/c P-1
a [Å]  9.35991(13) 12.1695(4) 11.35775(17) 14.6359(6) 10.0331(3) 
b [Å]  19.4751(3) 13.8697(6) 12.3482(2) 8.3887(3) 13.8107(5) 
c [Å]  17.2255(3) 13.9362(5) 13.2800(3) 27.1301(12) 14.4657(5) 
 [°]  90.00 90.00 117.0250(19) 90.00 100.141(3)
[°]  93.3452(13) 96.327(3) 104.5021(15) 96.813(4) 106.935(3)
 [°]  90.00 90.00 91.1715(13) 90.00 99.411(3)
Volume [Å3]  3134.61(8) 2337.93(15) 1586.69(5) 3307.4(2) 1837.79(11) 
Z 4 2 1 4 2 
Density 1.534 1.768  1.573 1.568 1.528 
Absorption 0.724 0.876 0.696 0.848 0.836
F(000) 1480 1248 768 1584 860
Crystal size [mm3]  0.47 x 0.11 x 0.10 0.19 x 0.14 x 0.04 0.37 x 0.23 x 0.16 0.14 x 0.07 x 0.05 0.20 x 0.12 x 0.05 
Crystal description yellow needle orange plate yellow block Orange needle orange plate
Theta range for 
data collection [°]  
 2.57 to 30.51 2.95 to 36.32 2.95 to 29.5 2.61 to 30.51 
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Index ranges  -17<=h<=17, -
19<=k<=19, -
19<=l<=19 
-18<=h<=18,  
-20<=k<=20,  
-22<=l<=22 
-18<=h<=19,  
-11<=k<=11,  
-36<=l<=34 
-14<=h<=14,  
-19<=k<=17,  
-20<=l<=18 
Reflections 
collected 
 24410* 59543 21611 20943 
Independent 
reflections 
 24410* 15362 [R(int) = 0.0247] 7893 [R(int) = 
0.0406] 
11219 [R(int) = 
0.0328] 
Reflections  18628 13058 6313 7958
Criterion for >2sigma(I) >2sigma(I) >2sigma(I) >2sigma(I) >2sigma(I)
Completeness to  99.9 % to 30.51° 99.8 % to 36.32° 99.74 % to 26.32° 99.9 % to 30.51° 
Absorption 
correction 
 Semi-empirical 
from equivalents 
Semi-empirical from 
equivalents 
Semi-empirical 
from equivalents 
Semi-empirical 
from equivalents 
Max. and min. 
transmission 
 0.9658 and 0.8980 0.8968 and 0.8362 1.0000 and 
0.8779 
0.9594 and 0.8045 
Data / restraints /  24410 / 0 / 320 15362 / 0 / 412 7893 / 0 / 406 11219 / 0 / 442
Goodness-of-fit on 1.097 1.032 1.116 1.021 0.899
Final R indices 
[I>2sigma(I)] 
 R1 = 0.0454, wR2 
= 0.1232 
R1 = 0.0271, wR2 = 
0.0772 
R1 = 0.0376, wR2 
= 0.0805 
R1 = 0.0360, wR2 
= 0.0627 
R indices (all data)  R1 = 0.0624, wR2 
= 0.1303 
R1 = 0.0336, wR2 = 
0.0786 
R1 = 0.0528, wR2 
= 0.0838 
R1 = 0.0601, wR2 
= 0.0657 
Largest diff. peak  1.109 and -0.844 0.797 and -0.595 0.714 and -0.649 0.715 and -0.853
CCDC number  837344 828860 820763 828861
* Due to the twin integration, there are no independent reflections. 
3.4. Catalytic trials with CpRu-based complexes of PN ligands 
Grotjahn et al. described the catalytic activity of the complex [CpRu(L)2(NCCH3)]PF6 with the PN 
ligand 2-diphenylphosphino-6-tert-butylpyridine (L) in the hydration of several terminal alkynes to give 
up to 99.9 % yield within 3 h with a catalyst loading of just 2 mol-%.25 
We used a protocol established for the catalytic hydration of ruthenium(II) pyridinyl phosphine 
complexes and [CpRu(NCCH3)3]PF6 as well as [CpRu(C10H8)]PF6 for the preparation of compounds of 
the type [CpRu(L)2(NCCH3)]PF6.25,56 The corresponding CpRu-precursor and two equivalents of the 
corresponding ligand were stirred at 60 °C in an oil bath over night (monitored by 31P NMR, see ESI). 
The results of the various catalytic hydration reactions with different ligands were unexpectedly 
disappointing (for details see ESI). None of the investigated complexes showed substantial catalytic 
activity in the hydration of 1-octyne. The highest conversion with 9 % after 22 h at 60 °C was found in 
a trial with [CpRu(C10H8)]PF6 and 4-MIPiPrNMe (1i) at a catalyst loading of 5 mol%.  
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4. Conclusions 
We prepared CpRu-complexes with imidazole-based PN ligands. Three types of coordination modes for 
the PN ligands have been found in the corresponding CpRu complexes: κ1P-monodentate, κ2P,N-, 
κ2N,N- and κ3N,N,N- chelating and μ-κP:κ2N,N-brigding. We have screened 11 imidazole-based PN 
ligands in the CpRu(II)-catalysed hydration of 1-octyne. Although the observed conversion rates are 
low to zero, some complexes show high selectivity for the formation of aldehyde over ketone. When 
poly(imidazolyl) ligands are used, the formation of coordinatively saturated complexes seems to prevent 
catalytic activity. Furthermore, in compounds with imidazol-2-ylphosphine ligands formation of 1,2-
phosphinylimidazole by P–C bond cleavage in the coordination sphere of the metal has been observed. 
This may be another deactivation path of these compounds thus limiting their use in catalytic 
applications. 
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Textual Abstract 
Piano-stool complexes of cyclopentadienyl ruthenium(II) with imidazole-based PN ligands have been 
screened for their catalytic activity in the hydration of 1-octyne. PN ligands used were imidazol-2-yl, -
4-yl and -5-yl phosphines. The catalytic trials in the presence of [CpRu(C10H8)]PF6 showed low activity 
in the hydration of 1-octyne to octanal. Deactivation of the CpRu(II) is attributed to two deactivation 
pathways. (i) Formation of coordinatively saturated complexes by polyimidazolyl ligands; Different 
types of coordination modes for the polyimidazolyl PN ligands were observed: κ1P-monodentate, 
κ2P,N-, κ2N,N- and κ3N,N,N- chelating and μ-κP:κ2N,N-brigding. (ii) P–C Bond cleavage in imidazol-2-
yl phosphine ligands. 
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Ruthenium Piano-Stool Complexes Bearing Imidazole-Based PN Ligands 
Peter C. Kunz*,a, Indre Thiel,a,b Anna Louisa Noffke,a,c Guido J. Reiß,a,‡ Fabian Mohrd,‡ and 
Bernhard Spinglere,‡ 
[a] Institut für Anorganische Chemie und Strukturchemie, Heinrich-Heine-Universität, Universitätsstr. 
1, D-40225 Düsseldorf, Germany, Fax: +49 211 8112287, E-mail: peter.kunz@uni-duesseldorf.de 
[b] Current address: Leibniz-Institut für Katalyse e. V. an der Universität Rostock, Albert-Einstein-Str. 
29a, D-18059 Rostock, Germany. 
[c] Current address: Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry, 
CV4 7AL, UK. 
[d] Bergische Universität Wuppertal, Fachbereich C - Anorganische Chemie, Gaußstr. 20, D-42119 
Wuppertal, Germany. 
[e] Anorganisch-Chemisches Institut, Universität Zürich-Irchel, Winterthurerstr. 190, CH-8057 Zürich, 
Switzerland. 
[‡] X-ray structure analysis. 
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Figure S1. 31P{1H} NMR spectra of the reaction of [CpRu(PPh3)(κP-1d)Cl] (4) with TlNO3 in 
(CD3)2CO gives [CpRu(PPh3)(κ2PN-1d)]NO3. 
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Figure S2. Solid-state structure of the cation [{CpRu(-2-N,N-’1-P-2b)}2]2+ in [{CpRu(μ - κ 2-N,N- 
κ’1-P-2b)}2](C6H5PO3H)2(C6H5PO3H2)2.  Displacement ellipsoids are drawn at 50 % level. The counter 
ions and hydrogen atoms are omitted for clarity.  
 
 
Figure S3. Molecular structure of the solvate [CpRu(PPh3)2Cl]·CHCl3. Displacement ellipsoids are 
drawn at 50 % level and hydrogen atoms are omitted for clarity. For the solvent free structure see 
reference 55. 
 
Table S1. 31P{1H} NMR shifts of the ligands (L) and the respective ruthenium complexes (C) as well as 
the coordination shift Δδ = δC –δL(in methanol-d4). 
Ligand δL(31P)/ppm δC(31P)/ppm Δδ(31P)/ppm 
2-MIPH (1a) –23.8 48.8; 116.2 72.6 
2-MIPNMe (1b) –29.6 34.7 64.3 
2-BIPNMe (2b) –61.3 11.7 73.0 
2-TIPNMe (3b) –90.1 0.4 90.5 
2-MIPdiPhNMe (1c) –28.7 38.5 67.2 
4-MIPNMe (1h) –24.8 24.8 49.6 
4-MIPiPr (1d) –30.6 29.3 60.0 
4-MIPiPrNMe (1i) –24.4 31.3 55.7 
4-MIPtBu (1e) –29.9 30.0 59.9 
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4-MIPtBuNMe (1j) –30.4 - - 
4-MIPPh (1f) –29.3 34.7 64.0 
 
Table S2. Preformed ruthenium complexes and their in situ catalytic activity in the hydration of 1-
octyne to 1-octanal. 
entry Precursor Ligand Conversion [% (h)] 
1 [CpRu(CH3CN)3]PF6 2-MIPH (1a) 0 (22) 
2 [CpRu(naphthaline)]PF6 2-MIPH (1a) 0 (22) 
3 [CpRu(NCCH3)3]PF6 2-MIPNMe (1b) 0 (22) 
4 [CpRu(naphthaline)]PF6 2-MIPNMe (1b) 0 (22) 
5 [CpRu(naphthaline)]PF6 2-BIPNMe (2b) 0 (22) 
6 [CpRu(naphthaline)]PF6 2-TIPNMe (3b) 0 (22) 
7 [CpRu(naphthaline)]PF6 2-MIPdiPhNMe (1c) 1 (24) 
8 [CpRu(naphthaline)]PF6 4-MIPNMe (1h) 0 (22) 
9 [CpRu(naphthaline)]PF6 4-MIPiPr (1d) 0 (22) 
10 [CpRu(naphthaline)]PF6 4-MIPiPrNMe (1i) 9 (22) 
11 [CpRu(NCCH3)3]PF6 4-MIPiPrNMe (1i) 0 (22) 
12 [CpRu(naphthaline)]PF6 4-MIPtBu (1e) 2 (24) 
13 [CpRu(naphthaline)]PF6 4-MIPtBuNMe(1j) 0 (22) 
14 [CpRu(naphthaline)]PF6 4-MIPPh (1f) 0 (22) 
Supporting Experimentals 
Synthesis of 4,5-diiodoimidazole 57,58 
Imidazole (8.4 g, 0.12 mol) and sodium hydroxide (14 g, 0.35 mol) are dissolved in 0.4 L water in an 1 
L round bottom flask. Potassium iodide (80 g, 0.48 mol) and iodine (55 g, 0.22 mol) are dissolved in 0.2 
L water. This solution is added drop wise to the imidazole / sodium hydroxide mixture at room 
temperature. A white solid precipitates and the solution is stirred over night. Acetic acid and sodium 
thiosulfate are added until the solution is clear and neutral. The white solid is filtered and washed with 
water. Recrystallization from ethanol leads to fine white crystals. (16 g, 41 %). 1H NMR (200 MHz, 
methanol-d4): δ = 7.79 (s, 1H, CH). 
Synthesis of 4,5-diiodo-2-isopropylimidazole 57 
2-Isopropylimidazole (11 g, 0.10 mol) and sodium hydroxide (14 g, 0.35 mol) are dissolved in 0.4 L 
water in a 1 L round bottom flask. Potassium iodide (80 g, 0.48 mol) and iodine (55 g, 0.22 mol) are 
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dissolved in 0.2 L water. This solution is added drop wise to the imidazole / sodium hydroxide mixture 
at room temperature. A white solid precipitates and the solution is stirred over night. Acetic acid and 
sodium thiosulfate are added until the solution is clear and neutral. The yellow solid is filtered and 
washed with water. Recrystallization from ethanol leads to fine white crystals. (16 g, 44 %). 1H-NMR 
(200 MHz, methanol-d4): δ = 1.30 (d, 6H, CH3), 3.05 (m, 1H, CH). EI MS (methanol): m/z = 362 [M+], 
235 [M+-I]. 
Synthesis of 4,5-diiodo-2-tert-butylimidazole 57 
2-tert-Butylimidazole (2.0 g, 16 mmol) and sodium hydroxide (2.0 g, 50 mmol) are dissolved in 100 mL 
water in an 500 mL round bottom flask. Potassium iodide (13 g, 78 mmol) and iodine (8.1 g, 32 mmol) 
are dissolved in 40 mL water. This solution is added drop wise to the imidazole / sodium hydroxide 
mixture at room temperature. A white solid precipitates and the solution is stirred over night. Acetic 
acid and sodium thiosulfate are added until the solution is clear and neutral. The yellow solid is filtered 
and washed with water. Recrystallization from ethanol leads to fine white crystals. (2.7 g, 44 %). 1H 
NMR (200 MHz, methanol-d4): δ = 1.35 (s, 9H, CH3). EI MS (methanol): m/z= 376 [M+], 193 [M+-I-
tBu]. 
Synthesis of 1-methyl-4,5-diiodoimidazole 59 
4,5-Diiodoimidazole (14 g, 40 mmol) is dissolved in thf. An equimolar amount of potassium tert-
butoxide (5.0 g, 44 mmol) is added to the solution at 0 °C and the solution is stirred for 1 h at that 
temperature. An equimolar amount of methyl iodide (2.7 mL, 44 mmol) is added drop wise to the 
solution at 0 °C. A white solid precipitates and the otherwise clear solution is stirred at room 
temperature over night. The white solid is filtered and washed with dichloromethane. The solvent is 
removed from the filtrate and the resulting yellow solid is dissolved in dichloromethane and filtered. 
The solvent is removed from the filtrate and the solid is dried under vacuum. (14 g, 94 %). 1H NMR 
(200 MHz, CDCl3): δ = 3.73 (s, 3H, CH3), 7.65 (s, 1H, CH). 
Synthesis of 1-methyl-4,5-diiodo-2-isopropylimidazole 59 
4,5-Diiodo-2-isopropylimidazole (8.0 g, 22 mmol) is dissolved in thf. An equimolar amount of 
potassium tert-butoxide (2.5 g, 22 mmol) is added to the solution at 0 °C and the solution is stirred for 1 
h at that temperature. An equimolar amount of methyl iodide (1.4 mL, 22 mmol)  is added drop wise to 
the solution at 0 °C. A white solid precipitates and the solution turns pink, later on yellow. The solution 
is stirred at room temperature over night. The white solid is filtered and washed with dichloromethane. 
The solvent is removed from the filtrate and the resulting brown oil is dissolved in dichloromethane and 
filtered. The solvent is removed from the filtrate and the oil is dried under vacuum. (7.9 g, 97 %). 1H 
NMR (200 MHz, CDCl3): δ = 1.32 (d, 6H, CH3), 3.05 (m, 2H, CH), 3.65 (s, 3H, CH3). EI MS 
(methanol): m/z = 376 [M+], 361 [M+-CH3], 249 [M+-I]. 
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Synthesis of 1-methyl-4,5-diiodo-2-tert-butylimidazole 59 
4,5-Diiodo-2-tert-butylimidazole (2.25 g, 6.00 mmol) is dissolved in thf. An equimolar amount of 
potassium tert-butoxide (0.7 g, 6 mmol) is added to the solution at 0 °C and the solution is stirred for 1 
h at that temperature. An equimolar amount of methyl iodide (0.9 mL, 6 mmol)  is added drop wise to 
the solution at 0 °C. A white solid precipitates and the solution turns orange-pink, later on yellow. The 
solution is stirred at room temperature over night. The white solid is filtered and washed with 
dichloromethane. The solvent is removed from the filtrate and the resulting yellow oil is dissolved in 
dichloromethane and filtered. The solvent is removed from the filtrate and the yellow solid is dried 
under vacuum. (2.1 g, 85 %). 1H-NMR (200 MHz, CDCl3): δ = 1.45 (s, 9 H, CH3), 3.82 (s, 3H, CH3). EI 
MS (methanol): m/z= 390 [M+], 375 [M+-CH3], 263 [M+-I], 207 [M+-CH3-I]. 
Synthesis of 1-methyl-4,5-diphenylimidazole 59 
4,5-Diphenylimidazole (6.6 g, 30 mmol) is dissolved in thf. An equimolar amount of potassium tert-
butoxide (3.4 g, 30 mmol) is added to the solution at 0 °C and the solution is stirred for 1 h at that 
temperature. The solution turns deep blue, later on pink with a white solid precipitating. An equimolar 
amount of methyl iodide (1.9 mL, 30 mmol) is added drop wise to the solution at 0 °C. The solution is 
stirred at room temperature over night. The solvent is removed and the white/pink residue is dissolved 
in 80 mL dichloromethane and filtered. The solvent from the orange filtrate is removed resulting in a 
light pink solid, which is dried under vacuum. (6.0 g, 89 %). 1H NMR (200 MHz, CDCl3): δ = 3.54 (s, 
3H, CH3), 7.14-7.55 (m, 10H, Ph), 7.64 (s, 1H, CH). EI MS (methanol): m/z= 234 [M+]. 
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Synthesis of 1-methyl-4-iodoimidazole  59 
1-Methyl-4,5-diiodoimidazole (6.5 g, 19 mol) is dissolved in thf. One equivalent of ethyl magnesium 
bromide (3 M in ether) is slowly added to the solution at 0 °C. A white solid forms immediately. The 
solution is stirred for 1 h, than water (0.4 mL) is added to the solution. The solution is stirred at room 
temperature over night. An equal volume of an ammonium chloride solution is added to the reaction 
mixture. The aqueous phase is washed with dichloromethane (3 x) and the combined organic phase is 
washed with a saturated sodium chloride solution (3 x). The organic phase is then dried over sodium 
sulfate, filtered and the solvent removed. The resulting yellow oil is dried under vacuum. (3.5 g, 89 %). 
1HNMR (200 MHz, CDCl3) δ = 3.71 (s, 3H, CH3), 6.99 (s, 1H, CH), 7.35 (s, 1H, CH). 
Synthesis of 1-methyl-4-iodo-2-isopropylimidazole 59 
1-Methyl-4,5-diiodo-2-isopropylimidazole (4.2 g, 11 mmol) is dissolved in thf. One equivalent of ethyl 
magnesium bromide (3 M in ether) is slowly added to the solution at 0 °C. The clear solution is stirred 
for 1 h, then water (0.4 mL) is added to the solution and a white solid forms. The solution is stirred at 
room temperature over night. An equal volume of an ammonium chloride solution is added to the 
reaction mixture. The aqueous phase is washed with dichloromethane (3 x) and the combined organic 
phase is washed with a saturated sodium chloride solution (3 x). The organic phase is then dried over 
sodium sulfate, filtered and the solvent removed. The resulting yellow oil is dried under vacuum. (2.5 g, 
91 %). 1H-NMR (200 MHz, CDCl3): δ = 1.31 (d, 6H, CH3), 3.00 (m, 1H, CH), 6.87 (s, 1H, CH). EI MS 
(methanol):m/z= 250 [M+], 235 [M+-CH3], 107 [M+-CH3-I]. 
Synthesis of 1-methyl-4-iodo-2-tert-butylimidazole 59 
1-Methyl-4,5-diiodo-2-tert-butylimidazole (2 g, 5 mmol) is dissolved in thf. One equivalent of ethyl 
magnesium bromide (3 M in ether) is slowly added to the solution at 0 °C. The clear solution is stirred 
for 1 h, then water (0.2 mL) is added to the solution and a white solid forms. The solution is stirred at 
room temperature over night. An equal volume of an ammonium chloride solution is added to the 
reaction mixture. The aqueous phase is washed with dichloromethane (3 x) and the combined organic 
phase is washed with a saturated sodium chloride solution (3 x). The organic phase is then dried over 
sodium sulfate, filtered and the solvent removed. The resulting yellow solid is dried under vacuum. (1.4 
g, 99 %). 1HNMR (200 MHz, CDCl3): δ = 1.46 (s, 9H, CH3), 3.77 (s, 3H, CH3), 6.87 (s, 1H, CH). EI 
MS (methanol): m/z = 264 [M+], 249 [M+-CH3], 121 [M+-I]. 
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